{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:25:01Z","timestamp":1789467901512,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2022QNA099"],"award-info":[{"award-number":["2022QNA099"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Putian","award":["2024SJYL048"],"award-info":[{"award-number":["2024SJYL048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04915-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:01:31Z","timestamp":1751385691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased PECAM-1 May be a potential pathological factor for vascular injury in T2DM patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Jun-Jun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Ming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"4915_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12933-021-01289-4","volume":"20","author":"A Ceriello","year":"2021","unstructured":"Ceriello, A. & Prattichizzo, F. Variability of risk factors and diabetes complications. Cardiovasc. Diabetol. 20 (1), 101. https:\/\/doi.org\/10.1186\/s12933-021-01289-4 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"4915_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1570161117666190502103733","volume":"18","author":"C Faselis","year":"2020","unstructured":"Faselis, C. et al. Microvascular complications of type 2 diabetes mellitus. Curr. Vasc Pharmacol. 18 (2), 117\u2013124. https:\/\/doi.org\/10.2174\/1570161117666190502103733 (2020).","journal-title":"Curr. Vasc Pharmacol."},{"issue":"7","key":"4915_CR3","first-page":"577","volume":"61","author":"K Gotsch","year":"1972","unstructured":"Gotsch, K., Klein, W. W., Leb, G., Pavek, P. & Passath, A. H\u00e4modynamische vergleichsuntersuchungen verschiedener Herzglykoside [Comparative hemodynamic studies on various heart glycosides]. Z. Kreislaufforsch. 61 (7), 577\u2013587 (1972).","journal-title":"Z. Kreislaufforsch"},{"issue":"1","key":"4915_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm0106-75","volume":"12","author":"S Smyth","year":"2006","unstructured":"Smyth, S. & Heron, A. Diabetes and obesity: the twin epidemics. Nat. Med. 12 (1), 75\u201380. https:\/\/doi.org\/10.1038\/nm0106-75 (2006).","journal-title":"Nat. Med."},{"key":"4915_CR5","doi-asserted-by":"publisher","first-page":"1191426","DOI":"10.3389\/fendo.2023.1191426","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu, H., Wang, X., Gao, H., Yang, C. & Xie, C. Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy. Front. Endocrinol. (Lausanne). 14, 1191426. https:\/\/doi.org\/10.3389\/fendo.2023.1191426 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"4915_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","volume":"42","author":"WB Horton","year":"2021","unstructured":"Horton, W. B. & Barrett, E. J. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr. Rev. 42 (1), 29\u201355. https:\/\/doi.org\/10.1210\/endrev\/bnaa025 (2021).","journal-title":"Endocr. Rev."},{"issue":"3","key":"4915_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","volume":"23","author":"P Lertkiatmongkol","year":"2016","unstructured":"Lertkiatmongkol, P., Liao, D., Mei, H., Hu, Y. & Newman, P. J. Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31). Curr. Opin. Hematol. 23 (3), 253\u2013259. https:\/\/doi.org\/10.1097\/MOH.0000000000000239 (2016).","journal-title":"Curr. Opin. Hematol."},{"key":"4915_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.lfs.2017.11.002","volume":"193","author":"D Liao","year":"2018","unstructured":"Liao, D., Mei, H., Hu, Y., Newman, D. K. & Newman, P. J. CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity. Life Sci. 193, 186\u2013193. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.002 (2018).","journal-title":"Life Sci."},{"issue":"3","key":"4915_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00441-013-1779-3","volume":"355","author":"JR Privratsky","year":"2014","unstructured":"Privratsky, J. R. & Newman, P. J. PECAM-1: regulator of endothelial junctional integrity. Cell. Tissue Res. 355 (3), 607\u2013619. https:\/\/doi.org\/10.1007\/s00441-013-1779-3 (2014).","journal-title":"Cell. Tissue Res."},{"issue":"7","key":"4915_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15 (7), 539\u2013553 (1998).","journal-title":"Diabet. Med."},{"issue":"9","key":"4915_CR11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00125-008-1062-4","volume":"51","author":"R Djaberi","year":"2008","unstructured":"Djaberi, R. et al. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia 51 (9), 1581\u20131593. https:\/\/doi.org\/10.1007\/s00125-008-1062-4 (2008).","journal-title":"Diabetologia"},{"key":"4915_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/s0140-6736(97)90023-4","volume":"350","author":"ED Lehmann","year":"1997","unstructured":"Lehmann, E. D., Riley, W. A., Clarkson, P. & Gosling, R. G. Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350, S14\u2013S9. https:\/\/doi.org\/10.1016\/s0140-6736(97)90023-4 (1997).","journal-title":"Lancet"},{"issue":"6","key":"4915_CR13","doi-asserted-by":"publisher","first-page":"e3159","DOI":"10.1002\/dmrr.3159","volume":"35","author":"L Fuso","year":"2019","unstructured":"Fuso, L., Pitocco, D. & Antonelli-Incalzi, R. Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension. Diabetes Metab. Res. Rev. 35 (6), e3159. https:\/\/doi.org\/10.1002\/dmrr.3159 (2019).","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"3","key":"4915_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","volume":"30","author":"A Oikawa","year":"2010","unstructured":"Oikawa, A. et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler. Thromb. Vasc Biol. 30 (3), 498\u2013508. https:\/\/doi.org\/10.1161\/ATVBAHA.109.200154 (2010).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"3","key":"4915_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/CIRCRESAHA.112.300598","volume":"112","author":"G Spinetti","year":"2013","unstructured":"Spinetti, G. et al. Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155\/FOXO3a signaling pathway. Circ. Res. 112 (3), 510\u2013522. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.300598 (2013).","journal-title":"Circ. Res."},{"issue":"4","key":"4915_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/JLP.JLP_148_16","volume":"9","author":"D Bhattacharjee","year":"2017","unstructured":"Bhattacharjee, D. et al. Histopathological study with immunohistochemical expression of vascular endothelial growth factor in placentas of hyperglycemic and diabetic women. J. Lab. Phys. 9 (4), 227\u2013233. https:\/\/doi.org\/10.4103\/JLP.JLP_148_16 (2017).","journal-title":"J. Lab. Physicians"},{"issue":"8","key":"4915_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.placenta.2011.04.015","volume":"32","author":"M Higgins","year":"2011","unstructured":"Higgins, M., Felle, P., Mooney, E. E., Bannigan, J. & McAuliffe, F. M. Stereology of the placenta in type 1 and type 2 diabetes. Placenta 32 (8), 564\u2013569. https:\/\/doi.org\/10.1016\/j.placenta.2011.04.015 (2011).","journal-title":"Placenta"},{"issue":"11","key":"4915_CR18","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1210\/jc.2019-00980","volume":"104","author":"GP Fadini","year":"2019","unstructured":"Fadini, G. P., Albiero, M., Bonora, B. M. & Avogaro, A. Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects. J. Clin. Endocrinol. Metab. 104 (11), 5431\u20135444. https:\/\/doi.org\/10.1210\/jc.2019-00980 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4915_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S2213-8587(13)70025-1","volume":"1","author":"HC Gerstein","year":"2013","unstructured":"Gerstein, H. C. & Werstuck, G. H. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol. 1 (1), 71\u201378. https:\/\/doi.org\/10.1016\/S2213-8587(13)70025-1 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"4915_CR20","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2337\/dbi17-0044","volume":"67","author":"CDA Stehouwer","year":"2018","unstructured":"Stehouwer, C. D. A. Microvascular dysfunction and hyperglycemia: A vicious cycle with widespread consequences. Diabetes 67 (9), 1729\u20131741. https:\/\/doi.org\/10.2337\/dbi17-0044 (2018).","journal-title":"Diabetes"},{"issue":"5","key":"4915_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1083\/jcb.114.5.1059","volume":"114","author":"SM Albelda","year":"1991","unstructured":"Albelda, S. M., Muller, W. A., Buck, C. A. & Newman, P. J. Molecular and cellular properties of PECAM-1 (endoCAM\/CD31): a novel vascular cell-cell adhesion molecule. J. Cell. Biol. 114 (5), 1059\u20131068. https:\/\/doi.org\/10.1083\/jcb.114.5.1059 (1991).","journal-title":"J. Cell. Biol."},{"issue":"2","key":"4915_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/a:1009092107382","volume":"3","author":"Z Zhou","year":"1999","unstructured":"Zhou, Z., Christofidou-Solomidou, M., Garlanda, C. & DeLisser, H. M. Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 3 (2), 181\u2013188. https:\/\/doi.org\/10.1023\/a:1009092107382 (1999).","journal-title":"Angiogenesis"},{"issue":"2\u20133","key":"4915_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1242\/dmm.000547","volume":"1","author":"HY Stevens","year":"2008","unstructured":"Stevens, H. Y. et al. PECAM-1 is a critical mediator of atherosclerosis. Dis. Model. Mech. 1 (2\u20133), 175\u2013181. https:\/\/doi.org\/10.1242\/dmm.000547 (2008). discussion 179.","journal-title":"Dis. Model. Mech."},{"key":"4915_CR24","doi-asserted-by":"crossref","unstructured":"Elias, C. G. 3rd et al. Ligation of CD31\/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils. Eur. J. Immunol. 28(6), 1948-58 (1998).","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<1948::AID-IMMU1948>3.0.CO;2-C"},{"issue":"592","key":"4915_CR25","doi-asserted-by":"publisher","first-page":"eaba6480","DOI":"10.1126\/scitranslmed.aba6480","volume":"13","author":"M Gu","year":"2021","unstructured":"Gu, M. et al. iPSC-endothelial cell phenotypic drug screening and in Silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension. Sci. Transl. Med. 13 (592), eaba6480. https:\/\/doi.org\/10.1126\/scitranslmed.aba6480 (2021).","journal-title":"Sci. Transl Med."},{"issue":"1\u20132","key":"4915_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000480662","volume":"101","author":"Z Dong","year":"2018","unstructured":"Dong, Z. et al. Sulphonated Formononetin induces angiogenesis through vascular endothelial growth factor\/camp response Element-Binding protein\/early growth response 3\/vascular cell adhesion molecule 1 and Wnt\/\u03b2-Catenin signaling pathway. Pharmacology 101 (1\u20132), 76\u201385. https:\/\/doi.org\/10.1159\/000480662 (2018).","journal-title":"Pharmacology"},{"issue":"1","key":"4915_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jcdd3010006","volume":"3","author":"J Yang","year":"2016","unstructured":"Yang, J., Shah, S., Olson, T. M. & Xu, X. Modeling GATAD1-Associated dilated cardiomyopathy in adult zebrafish. J. Cardiovasc. Dev. Dis. 3 (1), 6. https:\/\/doi.org\/10.3390\/jcdd3010006 (2016).","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"5","key":"4915_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.cellsig.2014.01.013","volume":"26","author":"X Ma","year":"2014","unstructured":"Ma, X., Li, J., Brost, B., Cheng, W. & Jiang, S. W. Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas. Cell. Signal. 26 (5), 959\u2013967. https:\/\/doi.org\/10.1016\/j.cellsig.2014.01.013 (2014).","journal-title":"Cell. Signal."},{"issue":"21","key":"4915_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.114.015023","volume":"132","author":"NA Almontashiri","year":"2015","unstructured":"Almontashiri, N. A. et al. 9p21.3 coronary artery disease risk variants disrupt TEAD transcription factor-Dependent transforming growth factor \u03b2 regulation of p16 expression in human aortic smooth muscle cells. Circulation 132 (21), 1969\u20131978. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.015023 (2015).","journal-title":"Circulation"},{"issue":"10","key":"4915_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc3805","volume":"14","author":"ZM Ramdzan","year":"2014","unstructured":"Ramdzan, Z. M. & Nepveu, A. CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers. Nat. Rev. Cancer. 14 (10), 673\u2013682. https:\/\/doi.org\/10.1038\/nrc3805 (2014).","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"4915_CR31","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1111\/jcmm.13727","volume":"22","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via Inhibition of the CUX1\/FGF1\/HGF signalling pathway. J. Cell. Mol. Med. 22 (10), 4760\u20134770. https:\/\/doi.org\/10.1111\/jcmm.13727 (2018).","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"4915_CR32","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1161\/01.atv.20.11.e83","volume":"20","author":"R De Martin","year":"2000","unstructured":"De Martin, R., Hoeth, M., Hofer-Warbinek, R. & Schmid, J. A. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler. Thromb. Vasc. Biol. 20 (11), E83\u2013E88. https:\/\/doi.org\/10.1161\/01.atv.20.11.e83 (2000).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"4","key":"4915_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/clinchem\/47.4.624","volume":"47","author":"MJ Duffy","year":"2001","unstructured":"Duffy, M. J. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin. Chem. 47 (4), 624\u2013630 (2001).","journal-title":"Clin. Chem."},{"issue":"22","key":"4915_CR34","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1158\/0008-5472.CAN-13-0123","volume":"73","author":"KH Bramswig","year":"2013","unstructured":"Bramswig, K. H. et al. Soluble carcinoembryonic antigen activates endothelial cells and tumor angiogenesis. Cancer Res. 73 (22), 6584\u20136596. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0123 (2013).","journal-title":"Cancer Res."},{"issue":"3","key":"4915_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hep.31076","volume":"72","author":"ZR Dong","year":"2020","unstructured":"Dong, Z. R. et al. TMPRSS4 drives angiogenesis in hepatocellular carcinoma by promoting HB-EGF expression and proteolytic cleavage. Hepatology 72 (3), 923\u2013939. https:\/\/doi.org\/10.1002\/hep.31076 (2020).","journal-title":"Hepatology"},{"issue":"7","key":"4915_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/j.1538-7836.2007.02537.x","volume":"5","author":"YQ Ma","year":"2007","unstructured":"Ma, Y. Q., Qin, J. & Plow, E. F. Platelet integrin alpha(IIb)beta(3): activation mechanisms. J. Thromb. Haemost. 5 (7), 1345\u20131352. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02537.x (2007).","journal-title":"J. Thromb. Haemost"},{"issue":"6","key":"4915_CR37","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11011-021-00726-3","volume":"36","author":"K Qin","year":"2021","unstructured":"Qin, K., Tian, G., Zhou, D., Chen, G. & Circular RNA circ-ARFIP2 regulates proliferation, migration and invasion in human vascular smooth muscle cells via miR-338-3p-dependent modulation of KDR. Metab. Brain Dis. 36 (6), 1277\u20131288. https:\/\/doi.org\/10.1007\/s11011-021-00726-3 (2021).","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"4915_CR38","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","volume":"19","author":"K Holmes","year":"2007","unstructured":"Holmes, K., Roberts, O. L., Thomas, A. M. & Cross, M. J. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic Inhibition. Cell. Signal. 19 (10), 2003\u20132012. https:\/\/doi.org\/10.1016\/j.cellsig.2007.05.013 (2007).","journal-title":"Cell. Signal."},{"key":"4915_CR39","doi-asserted-by":"publisher","first-page":"1234104","DOI":"10.3389\/fphys.2023.1234104","volume":"14","author":"W Nan","year":"2023","unstructured":"Nan, W., He, Y., Wang, S. & Zhang, Y. Molecular mechanism of VE-cadherin in regulating endothelial cell behaviour during angiogenesis. Front. Physiol. 14, 1234104. https:\/\/doi.org\/10.3389\/fphys.2023.1234104 (2023).","journal-title":"Front. Physiol."},{"issue":"4","key":"4915_CR40","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10439-011-0507-y","volume":"40","author":"SD Chase","year":"2012","unstructured":"Chase, S. D., Magnani, J. L. & Simon, S. I. E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease. Ann. Biomed. Eng. 40 (4), 849\u2013859. https:\/\/doi.org\/10.1007\/s10439-011-0507-y (2012).","journal-title":"Ann. Biomed. Eng."},{"key":"4915_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.matbio.2018.05.007","volume":"78\u201379","author":"M Krolikoski","year":"2019","unstructured":"Krolikoski, M., Monslow, J. & Pur\u00e9, E. The CD44-HA axis and inflammation in atherosclerosis: A Temporal perspective. Matrix Biol. 78\u201379, 201\u2013218. https:\/\/doi.org\/10.1016\/j.matbio.2018.05.007 (2019).","journal-title":"Matrix Biol."},{"key":"4915_CR42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fimmu.2018.00745","volume":"9","author":"A Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e, A. & Lecarpentier, Y. Crosstalk between peroxisome Proliferator-Activated receptor gamma and the canonical WNT\/\u03b2-Catenin pathway in chronic inflammation and oxidative stress during carcinogenesis. Front. Immunol. 9, 745. https:\/\/doi.org\/10.3389\/fimmu.2018.00745 (2018).","journal-title":"Front. Immunol."},{"issue":"1","key":"4915_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41392-021-00625-0","volume":"6","author":"L Gan","year":"2021","unstructured":"Gan, L. et al. CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. Signal. Transduct. Target. Ther. 6 (1), 223. https:\/\/doi.org\/10.1038\/s41392-021-00625-0 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"4915_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1152\/physiol.00026.2020","volume":"36","author":"D Vestweber","year":"2021","unstructured":"Vestweber, D. Vascular endothelial protein tyrosine phosphatase regulates endothelial function. Physiol. (Bethesda). 36 (2), 84\u201393. https:\/\/doi.org\/10.1152\/physiol.00026.2020 (2021).","journal-title":"Physiol. (Bethesda)"},{"issue":"6","key":"4915_CR45","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.21037\/apm-20-1825","volume":"9","author":"J Jiang","year":"2020","unstructured":"Jiang, J., Chen, Y., Zhang, M., Zhou, H. & Wu, H. Relationship between CD177 and the vasculogenic mimicry, clinicopathological parameters, and prognosis of epithelial ovarian cancer. Ann. Palliat. Med. 9 (6), 3985\u20133992. https:\/\/doi.org\/10.21037\/apm-20-1825 (2020).","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"4915_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong, P. et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal. Transduct. Target. Ther. 7 (1), 131. https:\/\/doi.org\/10.1038\/s41392-022-00955-7 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3\u20134","key":"4915_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lfs.2010.06.001","volume":"87","author":"JR Privratsky","year":"2010","unstructured":"Privratsky, J. R., Newman, D. K. & Newman, P. J. PECAM-1: conflicts of interest in inflammation. Life Sci. 87 (3\u20134), 69\u201382. https:\/\/doi.org\/10.1016\/j.lfs.2010.06.001 (2010).","journal-title":"Life Sci."},{"issue":"6","key":"4915_CR48","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3892\/mmr.2020.11060","volume":"21","author":"X Xie","year":"2020","unstructured":"Xie, X. et al. Low shear stress induces endothelial cell apoptosis and monocyte adhesion by upregulating PECAM-1 expression. Mol. Med. Rep. 21 (6), 2580\u20132588. https:\/\/doi.org\/10.3892\/mmr.2020.11060 (2020).","journal-title":"Mol. Med. Rep."},{"key":"4915_CR49","unstructured":"Fostamatinib [M]. Drugs and Lactation Database (LactMed\u00ae). Bethesda. (2006)."},{"key":"4915_CR50","doi-asserted-by":"publisher","unstructured":"Paik, J. & Fostamatinib A Review in Chronic Immune Thrombocytopenia. Drugs 81(8), 935\u2013943 https:\/\/doi.org\/10.1007\/s40265-021-01540-y (2021).","DOI":"10.1007\/s40265-021-01540-y"},{"issue":"9","key":"4915_CR51","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/ATVBAHA.111.230847","volume":"31","author":"I Hilgendorf","year":"2011","unstructured":"Hilgendorf, I. et al. The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31 (9), 1991\u20131999. https:\/\/doi.org\/10.1161\/ATVBAHA.111.230847 (2011).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"6","key":"4915_CR52","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1093\/rheumatology\/keaa732","volume":"60","author":"Y Tanaka","year":"2021","unstructured":"Tanaka, Y., Millson, D., Iwata, S. & Nakayamada, S. Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study. Rheumatol. (Oxford). 60 (6), 2884\u20132895. https:\/\/doi.org\/10.1093\/rheumatology\/keaa732 (2021).","journal-title":"Rheumatol. (Oxford)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04915-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04915-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04915-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:33:21Z","timestamp":1760715201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04915-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04915-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The Funding section in the original version of this Article was omitted. It now reads: This work was supported by Fujian provincial health technology project (grant number: 2022QNA099), Science and Technology Project of Putian (grant number: 2024SJYL048), and Natural Science Foundation of Fujian Province (grant number: 2025J011534).","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22001"}}